Home » Topics » BioWorld Science

BioWorld Science
RSS

Reata initiates first-in-human study with allosteric RORgammat inhibitor RTA-1701

June 22, 2018

PTC Therapeutics presents updated preliminary data from FIREFISH

June 22, 2018

Metastatic breast cancer regression by immunotherapy with TILs enriched for neoantigen reactivity

June 22, 2018

FDA grants QIDP designation to ACX-362E to treat C. difficile infection

June 22, 2018

Shanghai Meton Pharmaceutical patents NADP+ inhibitors

June 21, 2018

MTHFD2 inhibitors identified at Daiichi Sankyo

June 21, 2018

Amgen discovers apelin receptor agonists

June 21, 2018

Teijin Pharma presents CDK4/cyclin D3 and/or CDK6/cyclin D3 inhibitors

June 21, 2018

Insights into the orthosteric and allosteric action of C5aR antagonists to guide drug development

June 21, 2018

TG Therapeutics and Novimmune enter global agreement to develop and commercialize TG-1801

June 21, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...